Discussion about this post

User's avatar
TSB's avatar

I was not expecting to see Healthcare on the far right of that duration chart. Given the large cash flow and dividend profiles of Managed care, Big Pharma and Medical Devices, I would expect it to be lower. It makes sense if you consider all of the biotech types however

Expand full comment
FXMacroGuy's avatar

One could almost say that the guys at the Fed are geniuses, because they got 7-9 hikes priced into the market while the S&P sits just 3.5% below its all-time high. At least stocks have the advantage that "duration measures for stocks tend to become guestimates" while for bonds it's tragically mathematical 🙂

Expand full comment
6 more comments...

No posts